Login

Ownership

Who owns Merus N.V., from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).

Stakes over 5%

Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.

Exited (13G) Paradigm BioCapital Advisors LP, Paradigm BioCapital Advisors GP LLC, Senai Asefaw, M.D. February 17, 2026

Paradigm BioCapital Advisors LP: 0.0% · 0 shares — Paradigm BioCapital Advisors GP LLC: 0.0% · 0 shares — Senai Asefaw, M.D.: 0.0% · 0 shares

Exited (13D) Genmab A/S, Genmab Holding II B.V. December 30, 2025

Genmab A/S: 0.0% · 0 shares — Genmab Holding II B.V.: 0.0% · 0 shares

5 more 5% stakes behind a free account

See every investor who has disclosed crossing 5% of Merus N.V..

Sign up free

Super investors holding Merus N.V.

Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Merus N.V. they hold. Together these 309 managers report 103.43% of shares outstanding.

Investor Position value Shares % of their portfolio % of company As of
Paradigm Biocapital Advisors LP $412M 4,373,770 11.71% 5.77% September 30, 2025
Avoro Capital Advisors LLC $334M 3,542,500 4.31% 4.67% September 30, 2025

307 more institutional holders behind a free account

See every manager reporting Merus N.V., how much of the company they hold, and how big the position is inside their own portfolio.

Sign up free

Funds holding Merus N.V.

Funds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 54 funds hold 6.60% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.

Fund Position value % of net assets % of company As of
VANGUARD HEALTH CARE FUND $134M 0.39% 2.67% July 31, 2025
Columbia Cornerstone Growth Fund $48.3M 0.72% 0.67% October 31, 2025

52 more funds behind a free account

See every fund holding Merus N.V. and what share of its net assets the position represents.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support